Morgane Mailhe

Aix-Marseille Université — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index9.3kcitations74works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Phylogenetic Studies(33), Bacterial Identification and Susceptibility Testing(27), Gut microbiota and health(17), Microbial Metabolism and Applications(12), Probiotics and Fermented Foods(10)

Publications74 total

Author Correction: Draft genome and description of Merdibacter massiliensis gen.nov., sp. nov., a new bacterium genus isolated from the human ileum
Scientific Reports·2025Open Access
Mycoplasma pneumoniae infection in adult inpatients during the 2023–24 outbreak in France (MYCADO): a national, retrospective, observational study
The Lancet Infectious Diseases·2025· 17 cited
Retraction notice to “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial” [International Journal of Antimicrobial Agents 56 (2020), 105949]
International Journal of Antimicrobial Agents·2024· 4 citedOpen Access
Retraction Note: Culture of previously uncultured members of the human gut microbiota by culturomics
Nature Microbiology·2024· 2 citedOpen Access
Retraction Note: Repertoire of the gut microbiota from stomach to colon using culturomics and next-generation sequencing
BMC Microbiology·2024· 1 citedOpen Access
Formes atypiques et prolongées de Mpox chez des patients immunodéprimés vivant avec le VIH
Médecine et Maladies Infectieuses Formation·2023
Relevant Article, White Papers and Other Documents Concerning The m RNA VACCINE: An Interesting Collection Useful to Better Understand some Phenomena and to Generate Hypotesys
International Journal of Forensic Research·2022Open Access
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
Reviews in Cardiovascular Medicine·2021· 33 citedOpen Access
WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
International Journal of Infectious Diseases·2021Open Access
Sepsis caused by Salmonella Paratyphi B producing an OXA-48 carbapenemase in a traveller
Journal of Global Antimicrobial Resistance·2021· 3 citedOpen Access
New human-associated species of the family Atopobiaceae and proposal to reclassify members of the genus Olsenella
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY·2021· 19 cited
High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report
International Journal of Infectious Diseases·2021· 13 citedOpen Access
Negativibacillus massiliensis gen. nov., sp. nov., a New Bacterial Genus Isolated from a Human Left Colon Sample
Microbiology Research·2021· 8 citedOpen Access
Granulocyte Macrophage Colony-Stimulating Factor-Specific Autoantibodies and Cerebral Nocardia With Pulmonary Alveolar Proteinosis
Open Forum Infectious Diseases·2020· 12 citedOpen Access
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Travel Medicine and Infectious Disease·2020· 262 citedOpen Access
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Travel Medicine and Infectious Disease·2020· 486 citedOpen Access
SARS‐CoV‐2 infection presenting as a febrile rash
Journal of the European Academy of Dermatology and Venereology·2020· 79 citedOpen Access
Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France
Travel Medicine and Infectious Disease·2020· 58 citedOpen Access
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
International Journal of Antimicrobial Agents·2020· 4.9k citedOpen Access
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
2020· 1.1k citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Didier Raoult(43), D. Ricaboni(31), Pierre‐Edouard Fournier(29), Jean‐Christophe Lagier(26), Véronique Vitton(19), Matthieu Million(13), Alban Benezech(13), Philippe Brouqui(12), F. Cadoret(12), Philippe Parola(10), Bernard La Scola(10), Philippe Gautret(9), Jean‐Marc Rolain(9), Barbara Doudier(8), Philippe Colson(8), Sophie Amrane(8), Stéphane Honoré(7), S. Khelaifia(7), Anthony Levasseur(7), Nicholas Armstrong(7)